Lexeo Therapeutics, Inc. (LXEO) stock
LXEONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.95+0.10 (+3.33%)
Close on Nov 18, 2026Market cap $242.04MP/E –Yield –
Lexeo Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Lexeo Therapeutics's market cap was $241.37M on Nov 11, 2026, against $541.65M a year earlier. Over the last 3 years it ranged from $20.77M to $547.59M, with a median of $305.98M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $241.37M | -55.8% |
| 2025 | Dec 31, 2025 | $545.50M | +150.8% |
| 2024 | Dec 31, 2024 | $217.52M | +892.5% |
| 2023 | Dec 29, 2023 | $21.92M | – |
See a number that looks wrong?